Increased Parental Anxiety With Increased Diabetes Risk

Share this content:
Increased Parental Anxiety With Increased Diabetes Risk
Increased Parental Anxiety With Increased Diabetes Risk

WEDNESDAY, July 12, 2017 (HealthDay News) -- Parents of children at increased genetic risk for type 1 diabetes and with positive islet autoantibody (IA) testing have increased anxiety, according to a study published online June 29 in Diabetes Care.

Suzanne Bennett Johnson, Ph.D., from the Florida State University College of Medicine in Tallahassee, and colleagues examined parent anxiety in response to genetic and IA testing in 6,799 children at increased genetic risk for type 1 diabetes in The Environmental Determinants of Diabetes in the Young study. Parental anxiety was assessed with the State Anxiety Inventory, which was completed when the child was 3, 6, and 15 months old, and annually thereafter. IA testing was conducted every three months for four years and every six months thereafter.

The researchers found that parents had high levels of anxiety in response to their child's increased genetic type 1 diabetes risk at study inception, with mothers more anxious than fathers, and parents with diabetes in the family more anxious than those without diabetes in the family. Parent anxiety decreased to normal levels in response to repeated IA-negative test results. In parents faced with an IA-positive (IA+) test result, anxiety increased; particularly high levels of anxiety were seen for parents faced with two or more types of IA+ results (all P < 0.001).

"IA+ results heighten parent anxiety, and parents faced with two or more types of IA+ results may experience considerable anxiety for longer periods," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »